|
IQVIA™ Real-World Insights Bibliography
| Identification of a hereditary angioedema cohort in a US ambulatory EMR database |
| Author(s): Brouwer E, Bratton E, Near A, Lang K, Mack C |
| Affiliations(s): |
Publication(s): Pharmacoepidemiol Drug Saf 2018; 27 (2): 136-137.
|
| Document Type(s): Poster, |
| Countries: |
C:
Y: |
Rare Diseases,
2018 |
|
L:
A: |
English
|
|
 |
| |
| |
| Rare disease development programs: An update |
| Author(s): Wu J, Want C, Horton DB, Petersen I, Oliveria S, Blackburn S, Jiang J, LoCasale R. |
| Affiliations(s): |
Publication(s): Pharmacoepidemiol Drug Saf 2018; 27 (2):5.
|
| Document Type(s): Poster, |
| Countries: |
C:
Y: |
Rare Diseases,
2018 |
|
L:
A: |
English
|
|
|
| |
| |
| WHAT INTERPRETATION OF ICERS IN ORPHAN DISEASES? A FRENCH EXAMPLE. |
| Author(s): Moutier Hélène; Bourguignon Sandrine; Maurel Frédérique; Bodaghi Charles |
| Affiliations(s): RWI IQVIA France |
Publication(s): ISPOR 2018
|
| Document Type(s): Poster, |
| Countries: France, |
C:
Y: |
Comparative Effectiveness & Health Technology Assessment, Health economics, Pricing and reimbursement, Rare Diseases,
2018 |
|
L:
A: |
English
Cost effectiveness, Pricing & Reimbursement, Willingness to pay, |
|
|
| |
| |
| Healthcare resource utilization and costs associated with long-term corticosteroid exposure in patients with systemic lupus erythematosus |
| Author(s): Kabadi S, Yeaw J, Bacani AK, Tafesse E, Bos K, Karkare S, DeKoven M, Vina ER |
| Affiliations(s): AstraZeneca, IQVIA |
Publication(s): Lupus
|
| Document Type(s): Article, |
| Countries: USA, |
| Click here for the abstract |
C:
Y: |
Rare Diseases,
2018 |
|
L:
A: |
English
Cost analysis, Retrospective cohort analysis, |
|
|
| |
| |
| Health Care Resource Utilization Among a US Cohort Treated for Hereditary Angioedema, 2010?2015 |
| Author(s): Tachdjian R, Johnson KE, Casso D, Oliveria SA, Devercelli G, Jain G. |
| Affiliations(s): Tachdjian R: UCLA School of Medicine; Johnson KE: IQVIA (formerly); Casso D: IQVIA; Oliveria SA: IQVIA; Devercelli G: Shire; Jain G: Shire |
Publication(s): 2018 American Academy of Allergy, Asthma and Immunology (AAAAI)/World Allergy Organization (WAO) Joint Congress
|
| Document Type(s): Poster, |
| Countries: USA, |
C:
Y: |
Patient Registries & Real-World Study Methods, Rare Diseases,
2018 |
|
L:
A: |
English
Cost analysis, Database Study, Epidemiological study, Retrospective database analysis, |
|
|
| |
| |
| Demographic Characteristics and Treatment Patterns among Patients Treated for Hereditary Angioedema in a U.S. Cohort, 2006-2015 |
| Author(s): Tachdjian R, Johnson KE, Casso D, Oliveria SA, Devercelli G, Jain G |
| Affiliations(s): Tachdjian R: UCLA School of Medicine (Department of Medicine and Pediatrics), Johnson KE: IQVIA (formerly); Casso D: IQVIA; Oliveria SA: IQVIA; Devercelli G: Shire; Jain G: Shire. |
Publication(s): 34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management
|
| Document Type(s): Abstract, |
| Countries: USA, |
C:
Y: |
Rare Diseases,
2018 |
|
L:
A: |
English
Database Study, Epidemiological study, Retrospective cohort analysis, Retrospective database analysis, |
|
|
| |
| |
| High levels of healthcare utilization prior to diagnosis in idiopathic pulmonary arterial hypertension support the feasibility of an early diagnosis algorithm: the SPHInX project
|
| Author(s): Rito Bergemann, James Allsopp, Harvey Jenner, Flora Ashley Daniels, Edmund Drage, Yevgeniy Samyshkin, Claude Schmitt, Steven Wood, David G. Kiely, Allan Lawrie
|
| Affiliations(s): "1GlaxoSmithKline, Brentford, Middlesex, UK
2Current affiliation: Evalueserve Life Sciences Healthcare, London, UK
3Scientific Computing Group, Sheffield Teaching Hospitals Foundation Trust, Sheffield, UK
4IQVIA, London, UK
5Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, UK
6National Pulmonary Hypertension Service (Sheffield), Sheffield Pulmonary Vascular Unit, Royal Hallamshire Hospital, Sheffield, UK
7INSIGNEO, University of Sheffield, Sheffield, UK"
|
Publication(s): Pulm Circ. 2018 Oct-Dec;8(4):2045894018798613. doi: 10.1177/2045894018798613.
|
| Document Type(s): Article, |
| Countries: UK, |
C:
Y: |
Cardiovascular disease, Database Validity and methodology, Rare Diseases, Respiratory disease,
2018 |
|
L:
A: |
English
Retrospective database analysis, |
|
|
| |
| |
| Real world data from hospital episode statistics can be used to determine patients at risk of idiopathic pulmonary arterial hypertension
|
| Author(s): "David G. Kiely MD, Allan Lawrie, Orla Doyle PhD, Valentina Salvatelli PhD, Flora Ashley Daniels PhD, Edmund Drage, Harvey Jenner, John Rigg, Claude Schmitt, Yevgeniy Samyshkin, Rito Bergemann
"
|
| Affiliations(s): 1Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Glossop Road, Sheffield, UK; 2Real-World & Analytical Solutions, IQVIA, London, UK; 3GSK, Brentford, Middlesex, UK; 4Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, UK; 5INSIGNEO, University of Sheffield, Sheffield, UK; 6Evalueserve UK Ltd, London, UK. 1 Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Glossop Road, Sheffield, UK. 2 Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, UK. 3 INSIGNEO, University of Sheffield, Sheffield, UK. 4 Real-World & Analytical Solutions, IQVIA, London, UK. 5 GlaxoSmithKline, Brentford, Middlesex, UK.
|
Publication(s): European Respiratory Journal 2018 52: Suppl. 62, PA3082.
|
| Document Type(s): Poster, |
| Countries: UK, |
C:
Y: |
Cardiovascular disease, Database Validity and methodology, Rare Diseases, Respiratory disease,
2018 |
|
L:
A: |
English
Retrospective database analysis, |
|
|
| |
| |
| Unspecified intestinal malabsorption in patients treated with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers: a retrospective analysis in primary care settings |
| Author(s): De Bortoli N1, Ripellino C2, Cataldo N3, Marchi S1 |
| Affiliations(s): 1 Gastroenterology Unit, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy
2 Department of Real World Evidence, HEOR Consultant Freelance, Milan, Italy
3 Department of Real World Evidence, QuintilesIMS, Milan, Italy |
Publication(s): Expert Opinion on Drug Safety.
doi: 10.1080/14740338.2017.1376647. [Epub ahead of print]
|
| Document Type(s): Article, |
| Countries: Germany, Italy, |
| Click here for the abstract |
C:
Y: |
Drug safety, Gastrointestinal disorders, Rare Diseases,
2017 |
|
L:
A: |
English
Clinical setting: Primary care, Database Study, Real World Data, Real World Evidence, Retrospective cohort analysis, Retrospective database analysis, |
|
|
| |
| |
| CLOSING THE EVIDENCE GAP FOR ORPHAN DRUGS: DO GERMAN REGULATORY REQUIREMENTS GIVE INCENTIVES FOR HIGH LEVEL EVIDENCE GENERATION?
|
| Author(s): Ana Babac, Roger-Axel Greiner, Doreen Bonduelle
|
| Affiliations(s): "QuintilesIMS, IMS Health GmbH & Co. OHG, Landshuter Allee 10, 80637 München
"
|
Publication(s): ISPOR 20th Annual European Congress, Glasgow
|
| Document Type(s): Poster, |
| Countries: Germany, |
| Click here for the abstract |
C:
Y: |
Rare Diseases,
2017 |
|
L:
A: |
English
Pricing & Reimbursement, Retrospective database analysis, |
|
|
| |
| |
 1 of 2 
|
|
